SCHEMBL29469845

SCHEMBL29469845

CC(C)(C)c1ccc(OCC(F)(F)F)c(I)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPT P10636 3/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
THRB P10828 1/20 0.41
G6PD P11413 1/20 0.41
ALOX15 P16050 1/20 0.41
CASP1 P29466 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP2C19 P33261 1/20 0.38
MAPK1 P28482 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
KIF11 P52732 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314198 1.00 KDM4E (0.41) KDM4EALDH1A1MAPTMEN1USP2
SCHEMBL2011293 0.87 KDM4E (0.41) KDM4EALDH1A1MAPTMEN1USP2
SCHEMBL24314196 0.83 KDM4E (0.57) KDM4EALDH1A1MAPTMEN1USP2
SCHEMBL4859856 0.81 KDM4E (0.42) KDM4EALDH1A1MAPTMEN1USP2
SCHEMBL20347963 0.81 KDM4E (0.42) KDM4EALDH1A1MAPTMEN1USP2
SCHEMBL20347950 0.78 KDM4E (0.42) KDM4EALDH1A1MAPTMEN1USP2
SCHEMBL18120346 0.77 CNR2 (0.45) KDM4EALDH1A1MAPTMEN1USP2
SCHEMBL24313794 0.76 KDM4E (0.41) KDM4EALDH1A1MAPTMEN1USP2
SCHEMBL24313892 0.76 CYP1A2 (0.54) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL29469932 0.76 CYP1A2 (0.54) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP disclosed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed